FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with cytological study of ascitic fluid before therapy, smears should be stained according to Felgen's technique to determine tumor ploidy. The values of gynecological status of a patient (reproductive period - 1, postmenopausal - 2), the presence (1) or absence (0) of hydrothorax, the size of residual tumor up to 2 cm (1) or above 2 cm (2) and tumor ploidy (aneuploid - 1 or diploid -2) should be applied for calculating canonic linear discriminant function (CLDF) by the following formula: CLDF=-4.35465+status code*1.28017+hydrothorax code*0.64462+residual tumor code*1.55890-ploidy code*0.65926. In case, if rating value is below discriminant value (DV=-0.94584) one should predict favorable prognosis of the disease mentioned; if this value is above DV - unfavorable prognosis. The method is simple and enables to carry out prediction at high accuracy.
EFFECT: higher efficiency of prediction.
1 dwg, 2 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
METHOD OF DETERMINING DURATION OF RECURRENCE-FREE INTERVAL IN SEROUS OVARIAN CANCER | 2015 |
|
RU2613302C1 |
METHOD FOR DETERMINING THE EFFECTIVENESS OF CHEMOTHERAPY WITH PLATINUM PREPARATIONS IN III-IV STAGE OVARIAN CANCER | 2020 |
|
RU2738167C1 |
METHOD FOR PREDICTION OF RECURRENT OVARIAN CARCINOMA | 2013 |
|
RU2530556C1 |
METHOD FOR CYTOLOGICAL DIAGNOSTICS AND PREDICTING THE FLOW OF WILMS TUMOR IN CHILDREN | 2001 |
|
RU2220416C2 |
METHOD FOR PREDICTING EWING'S TUMOR FLOW IN CHILDREN | 2003 |
|
RU2262105C2 |
METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
METHOD FOR PREDICTION OF RISK OF TUMOUR PROGRESSION IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2816339C1 |
MESONEPHROID OVARIAN CARCINOMA SPREAD PREDICTION METHOD | 2008 |
|
RU2354302C1 |
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS IN CASE OF ABUNDANT MALIGNANT NEOPLASMS | 2003 |
|
RU2222813C1 |
Authors
Dates
2007-11-10—Published
2006-05-02—Filed